Journal Mobile Options
Table of Contents
Vol. 79, No. 3, 2012
Issue release date: March 2012
Section title: Original Paper
Pathobiology 2012;79:162–168
(DOI:10.1159/000335642)

Mismatch Repair Proteins hMLH1 and hMSH2 Are Differently Expressed in the Three Main Subtypes of Sporadic Renal Cell Carcinoma

Stoehr C.a · Burger M.c · Stoehr R.a · Bertz S.a · Ruemmele P.d · Hofstaedter F.d · Denzinger S.c · Wieland W.F.c · Hartmann A.a · Walter B.b
aInstitute of Pathology, and bDepartment of Urology, University of Erlangen, Erlangen, cDepartment of Urology, and dInstitute of Pathology, University of Regensburg, Regensburg, Germany
email Corresponding Author

Bernhard Walter, MD

Department of Urology, University of Erlangen

DE–91054 Erlangen (Germany)

Tel. +49 91 318 223 860

E-Mail bernhard.walter@uk-erlangen.de


References

  1. Störkel S, Kristiansen G, Moch G: The importance of pathology and genetics for the diagnosis and therapy of renal cell carcinoma. Eur Urol 2007;6(suppl):601–674.
  2. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998;396:643–649.
  3. Loeb KR, Loeb LA: Significance of multiple mutations in cancer. Carcinogenesis 2000;21:379–385.
  4. Moxon ER, Rainey PB, Nowak MA, Lenski RE: Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr Biol 1994;4:24–33.
  5. Chang DK, Metzgar D, Wills C, Boland CR: Microsatellites in the eukaryotic DNA mismatch repair genes as modulators of evolutionary mutation rate. Genome Res 2001;11:1145–1146.
  6. Chen W, Jinks-Robertson S: Mismatch repair proteins regulate heteroduplex formation during mitotic recombination in yeast. Mol Cell Biol 1998;18:6525–6537.
  7. Kolodner RD, Marsischky GT: Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999;9:89–96.
  8. Richards RI, Sutherland GR: Simple repeat DNA is not replicated simply. Nat Genet 1994;6:114–116.
  9. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1999;58:5248–5257.
  10. Mongiat-Artus P, Miquel C, Flejou JF, et al: Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer. Virchows Arch 2006;449:238–243.

    External Resources

  11. Chen HC, Bhattacharyya N, Wang L, et al: Defective DNA repair genes in a primary culture of human renal cell carcinoma. J Cancer Res Clin Oncol 2000;126:185–190.
  12. Deguchi M, Shiina H, Igawa M, et al: DNA mismatch repair genes in renal cell carcinoma. J Urol 2003;169:2365–2371.
  13. Diakoumis E, Sourvinos G, Kiaris H, et al: Genetic instability in renal cell carcinoma. Eur Urol 1998;33:227–232.
  14. Gen H, Yamamoto S, Morimura K, et al: p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON/Shi mice treated with N-butyl-N-(4hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma. Jpn J Cancer Res 2001;92:1278–1283.
  15. Goessl C, Heicappell R, Munker R, et al: Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 1998;58:4728–4732.
  16. Kanomata N, Eble JN, Halling KC: Microsatellite instability is uncommon in young patients with renal cell carcinoma. Cancer Genet Cytogenet 1998;101:123–127.
  17. Shin KH, Ku JL, Kim WH, et al: Establishment and characterization of seven human renal cell carcinoma cell lines. BJU Int 2000;85:130–138.
  18. Steiner G, Sidransky D: Molecular differential diagnosis of renal carcinoma: from microscopes to microsatellites. Am J Pathol 1996;149:1791–1795.
  19. Thrash-Bingham CA, Salazar H, Freed JJ, et al: Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology. Cancer Res 1995;55:6189–6195.
  20. Leach FS, Koh M, Sharma K, et al: Mismatch repair gene mutations in renal cell carcinoma. Cancer Biol Ther 2002;1:530–536.
  21. Rubio-Del-Campo A, Salinas-Sánchez AS, Sánchez-Sánchez F, et al: Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma. BJU Int 2008;102:504–509.
  22. Charbonneau N, Amunugama R, Schmutte C, Yoder K, Fishel R: Evidence that hMLH3 functions primarily in meiosis and in hMSH2-hMSH3 mismatch repair. Cancer Biol Ther 2009;8:1411–1420.
  23. Catto JW, Azzouzi AR, Amira N, et al: Distinct patterns of microsatellite instability are seen in tumours of the urinary tract. Oncogene 2003;22:8699–8706.
  24. Danaee H, Nelson HH, Karagas MR, et al: Microsatellite instability at tetranucleotide repeats in skin and bladder cancer. Oncogene 2002;21:4894–4899.
  25. Singer G, Kallinowski T, Hartmann A, et al: Different types of microsatellite instability in ovarian carcinoma. Int J Cancer 2004;112:643–646.
  26. Burger M, Burger SJ, Denzinger S, et al: Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancer. Eur Urol 2006;50:770–775.
  27. Burger M, Denzinger S, Hammerschmied CG, et al: Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer. J Mol Med 2006;84:833–841.
  28. Grignon DJ, Bonsib SN, Moch H, et al: Tumours of the kidney; in Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds): Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, ARC Press, 2004, pp 10–34.
  29. Greene LF, Page D, Fleming D, Fritz A, et al: American Joint Committee on Cancer (AJCC) Cancer Staging Manual. New York, Springer, 2002.
  30. Sobin LH, Wittekind C: TNM Classification of Malignant Tumors. New York, Wiley & Sons, 2002.
  31. Stoehr R, Zietz S, Burger M, et al: Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol 2005;47:58–63.
  32. Futreal PA, Barrett JC, Wiseman RW: An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 1991;19:6977.
  33. Schlegel J, Bocker T, Zirngibl H, et al: Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 1995;426:223–227.
  34. Bubendorf L, Nocito A, Moch H, Sauter G: Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72–79.
  35. Catto JW, Xinarianos G, Burton JL, et al: Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 2003;105:484–490.
  36. Bender R, Lange S: Adjusting for multiple testing – when and how? J Clin Epidemiol 2001;54:343–349.
  37. Papadopoulos N, Nicolaides NC, Wei YF, et al: Mutation of a MutL homolog in hereditary colon cancer. Science 1994;263:1625–1629.
  38. Baiyee D, Banner B: Mismatch repair genes in renal cortical neoplasms. Hum Pathol 2006;37:185–189.
  39. Uchida T, Wada C, Wang C, et al: Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res 1994;54:3682–3685.
  40. Kloor M, Schwitalle Y, von Knebel-Doeberitz M, Wentzensen N: Tetranucleotide repeats in coding regions: no evidence for involvement in EMAST carcinogenesis. J Mol Med 2006;84:329–333.